This is a 65-year-old female with HCV cirrhosis that in the context of an US exploration due to unspecific abdominal pain is found with a liver mass of 4cm. The work up blood analysis shows a bilirubin of 2 mg/dL, alkaline phosphatase of 220 U/L, normal INR, and albumin of 34g/L. Abdominal and chest CT scan shows a liver mass in seg 4 of 3.5cm with atypical characteristics, LI-RADS-M, associated with a perihilar lymph node of 3cm in diameter, along with a lung nodule of 2cm. Biopsy is compatible with cholangiocarcinoma. Molecular study identified findings of FGFR2 fusions.

What is the first line option of treatment for patients with metastatic iCCA and well-preserved liver function?